金源米業(00677.HK)年度實現純利4021.2萬港元 末期息1.2港仙
格隆匯6月28日丨金源米業(00677.HK)發佈公吿,截至2021年3月31日止年度,實現收益16.14億港元,同比下降7%;公司股東應占本年度溢利4021.2萬港元,上年同期公司股東應占虧損2265.2萬港元;基本每股盈利2.4港仙;擬派末期股息每股1.2港仙。
公吿表示,是次轉虧為盈,主要是來自本財政年度於損益賬按公平值處理的金融資產的未變現淨收益,相對上一個財政年度則為於損益賬按公平值處理的金融資產的未變現淨虧損;及因受新冠疫情影響,越南便利店業務的經營虧損增加,包括使用權資產及物業、廠房機器及設備的減值虧損3900萬港元,因而抵銷了部分本財政年度的除税後淨溢利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.